Conditions Treated
Five conditions where the clinical evidence is strongest, and where most clients have already exhausted conventional pathways.
I
When SSRIs and conventional therapy have failed.
Ketamine acts on NMDA receptors to rapidly restore synaptic connectivity, often producing measurable relief within hours of the first infusion. Pooled clinical trials show a 67% antidepressant response rate among patients who have not responded to standard treatment.
II
Fibromyalgia, CRPS, neuropathic and post-surgical pain.
Targets central sensitization and neuroinflammatory pathways implicated in chronic pain syndromes that have not responded to conventional pain management. IV ketamine provides precise dose control and rapid onset.
III
Process trauma with reduced emotional reactivity.
Neuroplasticity-enhancing effects allow clients to process traumatic memories with reduced emotional reactivity. Veterans treated with six IV ketamine infusions showed a 44% reduction in PTSD severity scores and a 50% improvement in depression scores.
IV
A neurological window for deep work.
Creates a neurological window for deep therapeutic work and lasting emotional recalibration. Particularly effective when paired with structured integration coaching between sessions.
V
Restore sharpness, drive, equilibrium.
For high-performance professionals experiencing burnout, cognitive decline, or loss of drive. Restores sharpness and emotional equilibrium through measured infusion protocols designed around demanding schedules.
Eligibility
Treatment begins with a comprehensive intake and neurological assessment. Dosage, frequency, and integration are tailored to your unique profile.
Request Consultation